Form 4: CareDx CEO Sells Shares Under 10b5-1 Plan

CareDx, Inc. President and CEO John Walter Hanna Jr. reported the sale of 4,835 shares of common stock for approximately $24.00 per share, executed under a pre-arranged Rule 10b5-1 trading plan.

Summary

• John Walter Hanna Jr., President and CEO of CareDx, Inc., sold 4,835 shares of common stock.
• The sale occurred on June 4, 2026, with shares sold at a weighted average price of $24.00, ranging from $24.00 to $24.02.
• This transaction was conducted under a Rule 10b5-1 trading plan adopted by Mr. Hanna on December 13, 2024.
• Following the sale, Mr. Hanna beneficially owns 671,640 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing. While an insider sale can be a negative signal, the execution under a Rule 10b5-1 plan mitigates concerns about opportunistic selling based on non-public information.

Negatives

• The CEO sold a portion of his holdings, which could be perceived negatively by the market, although it was executed under a pre-planned trading strategy.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, as it solely reports a past transaction.

Industry Context

StockSavvy.ai notes that insider sales, even those conducted under Rule 10b5-1 plans, are closely watched by investors. Such transactions can sometimes lead to short-term market reactions, regardless of the underlying business performance.

Stakeholder Impact

• Shareholders: May interpret the CEO's sale as a signal, though the Rule 10b5-1 plan provides context that it was pre-planned.
• Management: Demonstrates adherence to established trading policies.
• Employees: May observe insider activity as an indicator of company health or executive confidence.

Key Dates

Keywords

Form 4, SEC Filing, Insider Trading, Rule 10b5-1, CareDx, CDNA, Stock Sale, CEO, Beneficial Ownership